ReviewJournal of nanobiotechnology2025
Two-dimensional nanomaterials for bone disease therapy: multifunctional platforms for regeneration, anti-infection and tumor ablation.
Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A multifunctional conductive physiomimetic scaffold: synergy of rGO coating and cannabis-derived nanotopography for infection-resistant bone repair.Frontiers in bioengineering and biotechnology · 2026Article
- Nanotechnology Driven Innovations in Modern Pharmaceutics: Therapeutics, Imaging, and Regeneration.Nanomaterials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Bone diseases, encompassing defects, infections, necrosis, osteoarthritis and tumors, present persistent clinical challenges, often unmet by conventional therapies due to limited efficacy and biocompatibility. Two-dimensional (2D) nanomaterials have emerged as powerful platforms with tunable physicochemical properties that enable efficient drug loading, controlled release and dynamic cellular modulation. Recent advances in 2D structures such as graphene, black phosphorus, layered double hydroxides, transition metal disulfides and MXenes demonstrate broad therapeutic potential across orthopedic applications. These include targeted drug delivery, photothermal tumor ablation, antimicrobial action and scaffold-based bone regeneration. By enabling precise control over biological interactions and therapeutic kinetics, 2D nanomaterials offer integrated solutions for multifaceted bone pathologies. This review outlines recent progress in their synthesis, functionalization and biomedical deployment, highlighting key breakthroughs and translational opportunities. We also discuss the barriers to clinical implementation and propose strategies to accelerate their adoption in next-generation bone therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.